Sonic Healthcare Limited(DE:SAB)
€11.97-0.03 (-1.07%)
DE:SAB
Sonic Healthcare Limited financials statements
€11.97
At close:-0.03 (-1.07%)
Sonic Healthcare Limited (SAB) Ratios
3 Followers
Sonic Healthcare Limited Ratios
DE:SAB's free cash flow for Q4 2026 was AU$419.19M. For the 2026 fiscal year, DE:SAB's free cash flow was decreased by AU$-304.25M and operating cash flow was AU$723.44M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.99 | 1.17 | 1.01 | 1.14 | 1.11 |
| Quick Ratio | 0.90 | 1.07 | 0.92 | 1.03 | 1.00 |
| Cash Ratio | 0.25 | 0.30 | 0.28 | 0.42 | 0.37 |
| Solvency Ratio | 0.18 | 0.18 | 0.19 | 0.25 | 0.38 |
| Operating Cash Flow Ratio | 0.54 | 0.58 | 0.46 | 0.78 | 1.07 |
| Short-Term Operating Cash Flow Coverage | 4.24 | 16.04 | 3.60 | 3561.82 | 9936.70 |
| Net Current Asset Value | AU$ -5.69B | AU$ -4.98B | AU$ -4.40B | AU$ -3.51B | AU$ -3.37B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.32 | 0.30 | 0.23 | 0.23 |
| Debt-to-Equity Ratio | 0.70 | 0.62 | 0.57 | 0.40 | 0.41 |
| Debt-to-Capital Ratio | 0.41 | 0.38 | 0.36 | 0.29 | 0.29 |
| Long-Term Debt-to-Capital Ratio | 0.29 | 0.29 | 0.25 | 0.18 | 0.18 |
| Financial Leverage Ratio | 2.01 | 1.93 | 1.87 | 1.75 | 1.80 |
| Debt Service Coverage Ratio | 3.30 | 5.91 | 3.28 | 17.13 | 28.37 |
| Interest Coverage Ratio | 5.34 | 16.18 | 3.65 | 9.43 | 26.80 |
| Debt to Market Cap | 0.36 | 0.27 | 0.24 | 0.10 | 0.10 |
| Interest Debt Per Share | 12.23 | 11.12 | 9.80 | 6.79 | 6.47 |
| Net Debt to EBITDA | 2.65 | 2.57 | 2.33 | 1.34 | 0.79 |
| Profitability Margins | |||||
| Gross Profit Margin | 27.65% | 33.05% | 26.08% | 84.29% | 36.67% |
| EBIT Margin | 9.92% | 9.71% | 9.87% | 12.50% | 23.18% |
| EBITDA Margin | 17.86% | 18.16% | 18.57% | 21.13% | 30.43% |
| Operating Profit Margin | 9.92% | 30.28% | 6.18% | 10.07% | 22.99% |
| Pretax Profit Margin | 7.53% | 7.78% | 8.18% | 11.43% | 22.32% |
| Net Profit Margin | 5.56% | 5.32% | 5.72% | 8.41% | 15.69% |
| Continuous Operations Profit Margin | 5.81% | 5.64% | 6.09% | 8.69% | 16.28% |
| Net Income Per EBT | 73.77% | 68.40% | 69.95% | 73.56% | 70.31% |
| EBT Per EBIT | 75.90% | 25.71% | 132.27% | 113.51% | 97.09% |
| Return on Assets (ROA) | 3.62% | 3.20% | 3.45% | 5.05% | 11.14% |
| Return on Equity (ROE) | 7.29% | 6.17% | 6.46% | 8.85% | 20.08% |
| Return on Capital Employed (ROCE) | 7.67% | 21.12% | 4.42% | 7.02% | 19.41% |
| Return on Invested Capital (ROIC) | 5.63% | 14.80% | 3.12% | 5.18% | 13.73% |
| Return on Tangible Assets | 9.03% | 8.17% | 8.97% | -46.72% | -131.96% |
| Earnings Yield | 5.92% | 3.98% | 4.18% | 4.10% | 9.25% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.09 | 7.23 | 6.56 | 7.97 | 7.64 |
| Payables Turnover | 6.66 | 14.46 | 21.06 | 22.87 | 24.18 |
| Inventory Turnover | 31.55 | 28.45 | 31.62 | 29.37 | 27.26 |
| Fixed Asset Turnover | 2.96 | 2.89 | 2.93 | 2.91 | 3.55 |
| Asset Turnover | 0.65 | 0.60 | 0.60 | 0.60 | 0.71 |
| Working Capital Turnover Ratio | 60.73 | 46.71 | 62.56 | 34.19 | 64.57 |
| Cash Conversion Cycle | 8.27 | 38.06 | 49.86 | 42.28 | 46.04 |
| Days of Sales Outstanding | 51.51 | 50.47 | 55.65 | 45.81 | 47.75 |
| Days of Inventory Outstanding | 11.57 | 12.83 | 11.54 | 12.43 | 13.39 |
| Days of Payables Outstanding | 54.80 | 25.24 | 17.33 | 15.96 | 15.10 |
| Operating Cycle | 63.08 | 63.30 | 67.19 | 58.23 | 61.14 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.84 | 2.69 | 2.25 | 3.13 | 4.66 |
| Free Cash Flow Per Share | 1.57 | 2.00 | 1.03 | 2.07 | 3.86 |
| Dividend Paid and CapEx Coverage Ratio | 1.21 | 1.53 | 0.99 | 1.51 | 2.67 |
| Capital Expenditure Coverage Ratio | 2.23 | 3.86 | 1.85 | 2.96 | 5.88 |
| Operating Cash Flow Coverage Ratio | 0.24 | 0.25 | 0.24 | 0.47 | 0.74 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.13 | 0.12 | 0.18 | 0.24 |
| Free Cash Flow Yield | 7.53% | 7.45% | 4.03% | 5.83% | 11.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.92 | 25.04 | 23.90 | 24.39 | 10.81 |
| Price-to-Sales (P/S) Ratio | 0.94 | 1.34 | 1.37 | 2.05 | 1.70 |
| Price-to-Book (P/B) Ratio | 1.23 | 1.55 | 1.54 | 2.16 | 2.17 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.27 | 13.42 | 24.83 | 17.16 | 8.54 |
| Price-to-Operating Cash Flow Ratio | 7.32 | 9.94 | 11.40 | 11.36 | 7.09 |
| Price-to-Earnings Growth (PEG) Ratio | 1.13 | 0.00 | -0.89 | -0.47 | 0.99 |
| Enterprise Value Multiple | 7.91 | 9.93 | 9.70 | 11.05 | 6.36 |
| Enterprise Value | 15.47B | 17.39B | 16.09B | 19.01B | 18.02B |
| EV to EBITDA | 7.91 | 9.93 | 9.70 | 11.05 | 6.36 |
| EV to Sales | 1.41 | 1.80 | 1.80 | 2.33 | 1.94 |
| EV to Free Cash Flow | 19.97 | 18.11 | 32.70 | 19.52 | 9.75 |
| EV to Operating Cash Flow | 11.01 | 13.41 | 15.01 | 12.92 | 8.09 |
| Tangible Book Value Per Share | -3.14 | -2.69 | -2.21 | -15.12 | -14.19 |
| Shareholders’ Equity Per Share | 16.88 | 17.29 | 16.63 | 16.47 | 15.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.28 | 0.26 | 0.24 | 0.27 |
| Revenue Per Share | 22.16 | 20.04 | 18.77 | 17.34 | 19.46 |
| Net Income Per Share | 1.23 | 1.07 | 1.07 | 1.46 | 3.05 |
| Tax Burden | 0.74 | 0.68 | 0.70 | 0.74 | 0.70 |
| Interest Burden | 0.76 | 0.80 | 0.83 | 0.91 | 0.96 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.18 | 0.03 | 0.49 | 0.47 | 0.40 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.31 | 2.52 | 2.10 | 2.15 | 1.52 |
Currency in AUD
